One in eight patients hospitalized with COVID-19 develop some form of shock, according to the American Heart Association’s COVID-19 Cardiovascular Disease Registry. And regardless of whether the shock ...
The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock. "Shock, ...
The biopharmaceutical industry has a noble calling to improve health and save lives. Efforts are often focused on chronic conditions and therapeutic areas with known high returns on investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback